Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection

Clinical and Experimental Immunology

Volumn 187, Issue 2, 2017, Pages 259-268

  Chukwuanukwu, R C ^a   Onyenekwe, C C ^a   Martinez Pomares, L ^b   Flynn, R ^c   Singh, S ^b   Amilo, G I ^a   Agbakoba, N R ^a   Okoye, J O ^a  

^a NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

co infection; cytokines; HIV; malaria; tuberculosis

Indexed keywords

ANTIMALARIAL AGENT; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; TUBERCULIN; TUBERCULOSTATIC AGENT; CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; INTERFERON PRODUCTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALARIA; MALE; MIXED INFECTION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TH2 CELL; CD4+ T LYMPHOCYTE; CELL CULTURE; COMPARATIVE STUDY; COMPLICATION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; PARASITOLOGY; TH1 TH2 BALANCE; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHILD; COINFECTION; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; MALARIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NIGERIA; TH1-TH2 BALANCE; TUBERCULIN; TUBERCULOSIS; YOUNG ADULT;

EID: 84995400164     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12861     Document Type: Article

References (43)

1. Al-Aska AI, Al-Anazi AR, AI-Subaci SS et al. CD4+ T-lymphopenia in HIV negative tuberculosis patients at King Khalid University Hospital in Riyadh, Saudi Arabia. Eur J Med Res 2011; 16:285–8.
2. Shaler CR, Horvath CN, Jeyanathan M, Xing Z. Within the enemy's camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis. Front Immunol 2013; 4:30.
3. World Health Organization (WHO). HIV/AIDS, TB, malaria and neglected tropical diseases. Geneva, Switzerland: WHO, 2013.
4. World Health Organization (WHO). Global tuberculosis TB report. Geneva, Switzerland: WHO, 2012.
5. Cavalcanti YV, Brelaz MC, Neves JK, Ferraz JC, Pereira VR. Role of TNF-alpha, IFN-gamma, and IL-10 in the development of pulmonary tuberculosis. Pulm Med 2012; 2012: 745483.
6. Newport MJ, Huxley CM, Huston S et al. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335: 1941–9.
7. Ottenhoff THM, Verreck FAW, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis 2005; 85:53–64S.
8. Wallis RS. Reactivation of latent tuberculosis by TNF blockade: the role of interferon. J Investig Dermatol Symp Proc 2004; 12:16–21.
9. Restrepo BI, Schlesinger LS. Host-pathogen interactions in tuberculosis patients with type 2 diabetes mellitus. Tuberculosis (Edinb) 2013; 93:S10–4.
10. Centers for Disease Control and Prevention Grand Rounds. The TB/HIV syndemic. Morb Mort Wkly Rep 2012; 61:484–89.
11. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011; 24:351–76.
12. World Health Organization (WHO). Global tuberculosis control: WHO report. Geneva, Switzerland: WHO, 2010.
13. Vitoria M, Granich R, Gilks CF et al. The global fight against HIV/AIDS, tuberculosis and malaria. Current status and future prospects. Am J Clin Pathol 2009; 131:844–8.
14. Bhutta ZA, Sommerfeld J, Lassi ZS, Salam RA, Das JK. Global burden, distribution and interventions for infectious diseases of poverty. Infect Dis Poverty 2014; 3:21.
15. Onyenekwe CC, Arinola OG, Salimonu LS. Detection of Plasmodium falciparum IgG and incidence of asymptomatic malaria in pregnant women in Nigeria. Indian J Malariol 2002; 39:3942.
16. Erhabor O, Babatunde S, Uko KE. Some haematological parameters in plasmodial parasitized HIV-infected Nigerians. Niger J Med 2006; 15:52–5.
17. Federal Ministry of Health (FMoH) Nigeria. National guidelines for implementing TB infection, control, intensified case finding and INH Preventive therapy (3Is) in Nigeria. Nigeria: Department of Public Health, FMoH, 2011.
18. Boccia D, Hargreaves J, De Stavola BL et al. The association between household economic position and prevalent TB in Zambia. A case control study. PLOS ONE 2011; 6:e208204.
19. Olson NA, Davidow AL, Winston CA, Chen MP, Gazmararian JA, Katz DJ. A national study of socio-economic status and tuberculosis rates by country of birth, United States, 1996-2005. BMC Public Health 2012; 12:18–365.
20. Handzel ZT, Barak B, Altman Y et al. Increased TH1 and TH2 type cytokine production in patients with active tuberculosis. Allergy Clin Immunol 2007; 9:479–83.
21. Day CL, Abrahams DA, Lerumo L et al. Functional capacity of Mycobacterium tuberculosis – specific T cell responses in humans is associated with mycobacterial load. J Immunol 2011; 187:2222–32.
22. Sutherland JS, Adetifa IM, Hill PC, Adegbola RA, Ota MOC. Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol 2009; 39:723–9.
23. Raja A. Immunology of tuberculosis. Indian J Med Res 2004; 120:213–32.
24. Orme IM, Roberts AD, Griffin JP, Abrams JS. Cytokine secretion by CD4 T lymphocyte acquired in response to Mycobacterium tuberculosis infection. J Immunol 1993; 151:518–25.
25. Lalvani A, Brookes R, Wilkinson RJ et al. Human cytocytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95:270–5.
26. Cooper AM, Mayer-Barber KD, Sher A. Role of innate cytokines in mycobacterial infection. Mucosal Immunol 2011; 4:252–60.
27. Mohan VP, Scanga CA, Yu K et al. Effect of tumour necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001; 69:1847–55.
28. Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Brilton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation and clearance of mycobacterial infection. J Immunol 2002; 168:4620–7.
29. Sasindran SJ, Torrelles JB. Mycobacterium tuberculosis infection in inflammation: what is beneficial for the host and for the bacterium? Front Microbiol 2011; 2:2.
30. Murphy K. Janeway's immunobiology, 8th edn. New York, NY: Garland Science–Taylor & Francis Group, 2012.
31. Kumar NP, Anuradha R, Suresh R et al. Suppressed type 1, type 2 and type 17 cytokine responses in active tuberculosis in children. Clin Vaccine Immunol 2011; 18:1856–64.
32. Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol 2008; 180:5771–7.
33. Mueller A-K, Behrends J, Hagens K, Mahlo J, Schaible UE, Schneider BE. Natural transmission of Plasmodium berghei exacerbates chronic tuberculosis in an experimental co-infection model. PLOS ONE 2012; 7:e48110.
34. Li X, Zhou X. Co-infection of tuberculosis and parasitic diseases in humans: a systematic review. Parasit Vectors 2013; 6:79.
35. World Health Organization (WHO). Global tuberculosis report 2012. ISBN 978 92 4156450 2, 2013. Available at: http://www.who.int/tb/publications/global_report/
36. Diedrich CR, Flynn JL. HIV-1/Mycobacterium tuberculosis co-infection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 2011; 79:1407–17.
37. Geldmacher C, Ngwenyama N, Schuetz A et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J Exp Med 2010; 207:2869–81.
38. Sarrazin H, Wilkinson KA, Andersson J et al. Association between tuberculin skin test reactivity, the memory CD4 cell subset, and circulating FoxP3-expressing cells in HIV infected persons. J Infect Dis 2009; 199:702–10.
39. Francischetti IMB. Does activation of the blood coagulation cascade play a role in malaria pathogenesis? Trends Parasitol 2008; 24:258–63.
40. Cohen C, Karstaedt A, Frean J et al. Increased Prevalence of severe malaria in HIV infected adults in South Africa. Clin Infect Dis 2005; 41:1631–7.
41. Page KR, Jedlicks AE, Fakheri B et al. Mycobacterium-induced potentiation of type I immune responses and protection against malaria are host specific. Infect Immun 2005; 73:8369–80.
42. Riley EM, Williamson KC, Greenwood BM, Kaslow DC. Human immune recognition of recombinant proteins representing discrete domains of the Plasmodium falciparum gamete surface protein Pf s 230. Parasite Immunol 1995; 11–9.
43. Zheng C, Xie P, Chen Y. Immune response induced by recombinant BCG expressing merozoite surface antigen 2 from Plasmodium falciparum. Vaccine 2001; 20:914–9.